Internal Medicine, Endocrinology, Diabetes, & Metabolism · Manati, PR
NPI
1073947834
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Suite 213 Mmc Professional Plaza, 200 Calle Hernandez Carrion
Manati, PR, 00674
Phone (787) 621-4828
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,394
60 services
Medicare patients, 2024
28
Average age 72
Drug cost, 2024
$5.8M
25,038 prescriptions
Company payments, 2025
$119
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sheila Mercado was code 99213 (office e&m - established), 54 times for 28 patients. In total Sheila Mercado billed 60 services in 3 codes, and Medicare paid $3,394.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 54 | 28 | $59.24 | $3,199 |
By year: 2022 $5,125 for 72 services; 2023 $4,768 for 74 services; 2024 $3,394 for 60 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sheila Mercado prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 3,830 prescriptions and refills. In total Sheila Mercado wrote 25,038 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 3,830 | 4,797 | 622 | $224K |
| Atorvastatin Calcium Generic | 1,978 | 2,651 | 399 | $15K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 1,420 | 1,534 | 208 | $936K |
| Glimepiride Generic | 1,258 | 1,616 | 237 | $15K |
| Metformin Hcl Generic | 1,168 | 1,519 | 244 | $5,564 |
| Rosuvastatin Calcium Generic | 1,100 | 1,468 | 229 | $9,939 |
| Glipizide Generic | 1,052 | 1,301 | 179 | $13K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 932 | 977 | 148 | $82K |
| Levothyroxine Sodium Generic | 847 | 1,079 | 172 | $7,289 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 812 | 854 | 128 | $525K |
| Trulicity Dulaglutide | 799 | 823 | 98 | $813K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 686 | 747 | 111 | $60K |
| Humalog Insulin Lispro | 624 | 671 | 88 | $105K |
| Farxiga Dapagliflozin Propanediol | 533 | 613 | 98 | $359K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 458 | 530 | 82 | $307K |
Brand drugs: 13,945 claims; generic drugs: 10,004 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheila Mercado $119 ($119 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $66.51.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66.51 |
| Lilly USA, LLC LLY | 2 | $52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.